Prognostic factors for spinal chordomas and chondrosarcomas treated with postoperative pencil-beam scanning proton therapy: a large, single-institution experience

Restricted access

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

OBJECTIVE

The aim of this paper was to evaluate the prognostic factors in surgical and adjuvant care for spinal chordomas and chondrosarcomas after surgery followed by high-dose pencil-beam scanning proton therapy (PBS-PT).

METHODS

From 1997 to 2016, 155 patients (61 female patients; median age 55 years) with spinal (cervical, n = 61; thoracic, n = 29; lumbar, n = 13; sacral, n = 46; pelvic, n = 6) classic chordomas (n = 116) and chondrosarcomas (n = 39; most were low grade) were treated with maximal safe resection followed by PBS-PT (median dose prescribed: 74 Gy [relative biological effectiveness], range 48.6–77 Gy). The majority of patients (n = 153, 98.7%) had undergone at least 1 resection prior to PBS-PT (median 1, range 0–5; biopsy only, n = 2). Fewer than half (45.1%) of the surgeries were rated as gross-total resections (GTRs) prior to PBS-PT. Surgical stabilization (SS) was present in 39% of all patients (n = 60). Ninety-one patients (59%) presented with macroscopic tumor at the start of PBS-PT. The median follow-up duration was 64.7 months (range 12.2–204.8 months).

RESULTS

The 5-year local tumor control, disease-free survival (DFS), and overall survival were 64.9% (95% CI 56.3%–73.5%), 59.4% (95% CI 50.6%–68.2%), and 77.9% (95% CI 70.6%–85.2%), respectively. In total, 63 patients (40.6%) experienced failure during the follow-up period: local only in 32 (20.6%), distal only in 7 (4.5%), local + distal in 19 (12.3%), surgical pathway failure (SPF) only in 2 (1.3%), local + SPF in 2 (1.3%), and distal + SPF in 1 (< 1%). Univariate analysis identified gross residual disease, the presence of SS, and treatment era prior to 2008 as highly significant for worse outcome, with all 3 remaining significant on multivariate analysis. The type of surgery (GTR or subtotal resection/biopsy) and whether GTR was achieved by en bloc or curettage did not show a significant prognostic effect. Surgical complications prior to PBS-PT were present in 42.5% of all surgically treated patients and were seen more commonly in patients with multiple surgical interventions (p = 0.005) and those operated on with the intent of en bloc resection (p = 0.006).

CONCLUSIONS

The extent of resection and metallic stabilization substantially influenced clinical outcomes for patients with spinal chordoma or chondrosarcoma despite high-dose adjuvant PBS-PT. Optimal upfront surgical management of these tumors continues to include GTR, as possible, with prompt adjuvant proton therapy.

ABBREVIATIONS CTCAE = Common Terminology Criteria for Adverse Events; DFS = disease-free survival; GTR = gross-total resection; IMPT = intensity-modulated proton therapy; LC = local control; OS = overall survival; PBS-PT = pencil-beam scanning proton therapy; PSI = Paul Scherrer Institute; PTV = planning treatment volume; PTV1 = PTV subclinical dose; PTV2 = PTV prescription dose; RBE = relative biological effectiveness; SPF = surgical pathway failure; SS = surgical stabilization.
Article Information

Contributor Notes

Correspondence Damien C. Weber: Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen, Switzerland. damien.weber@psi.ch; damiencharles.weber@uzh.ch.INCLUDE WHEN CITING Published online January 31, 2020; DOI: 10.3171/2019.11.SPINE1927.Disclosures Dr. Snider: consultant for Siemens Healthineers, Pyrexar, and Varian Medical Systems; and patent holder with ProtonGRID.
Headings
References
  • 1

    Ailon TTorabi RFisher CGRhines LDClarke MJBettegowda C: Management of locally recurrent chordoma of the mobile spine and sacrum: a systematic review. Spine (Phila Pa 1976) 41 (Suppl 20):S193S1982016

    • Search Google Scholar
    • Export Citation
  • 2

    Amendola LCappuccio MDe Iure FBandiera SGasbarrini ABoriani S: En bloc resections for primary spinal tumors in 20 years of experience: effectiveness and safety. Spine J 14:260826172014

    • Search Google Scholar
    • Export Citation
  • 3

    Bergh PGunterberg BMeis-Kindblom JMKindblom LG: Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91:120112122001

    • Search Google Scholar
    • Export Citation
  • 4

    Bjornsson JWold LEEbersold MJLaws ER: Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer 71:7357401993

    • Search Google Scholar
    • Export Citation
  • 5

    Boriani SBandiera SDonthineni RAmendola LCappuccio MDe Iure F: Morbidity of en bloc resections in the spine. Eur Spine J 19:2312412010

    • Search Google Scholar
    • Export Citation
  • 6

    Boriani SDe Iure FBandiera SCampanacci LBiagini RDi Fiore M: Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) 25:8048122000

    • Search Google Scholar
    • Export Citation
  • 7

    Boriani SGasbarrini ABandiera SGhermandi RLador R: En bloc resections in the spine: the experience of 220 patients during 25 years. World Neurosurg 98:2172292017

    • Search Google Scholar
    • Export Citation
  • 8

    Cummings BJHodson DIBush RS: Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 9:6336421983

  • 9

    DeLaney TFKepka LGoldberg SIHornicek FJGebhardt MCYoon SS: Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 67:146014692007

    • Search Google Scholar
    • Export Citation
  • 10

    DeLaney TFLiebsch NJPedlow FXAdams JWeyman EAYeap BY: Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas. J Surg Oncol 110:1151222014

    • Search Google Scholar
    • Export Citation
  • 11

    Holliday EBMitra HSSomerson JSRhines LDMahajan ABrown PD: Postoperative proton therapy for chordomas and chondrosarcomas of the spine: adjuvant versus salvage radiation therapy. Spine (Phila Pa 1976) 40:5445492015

    • Search Google Scholar
    • Export Citation
  • 12

    Indelicato DJRotondo RLBegosh-Mayne DScarborough MTGibbs CPMorris CG: A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine. Int J Radiat Oncol Biol Phys 95:2973032016

    • Search Google Scholar
    • Export Citation
  • 13

    Keisch MEGarcia DMShibuya RB: Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 75:3743771991

    • Search Google Scholar
    • Export Citation
  • 14

    Lomax A: Intensity modulation methods for proton radiotherapy. Phys Med Biol 44:1852051999

  • 15

    McDonald MWLinton ORMoore MGTing JYCohen-Gadol AAShah MV: Influence of residual tumor volume and radiation dose coverage in outcomes for clival chordoma. Int J Radiat Oncol Biol Phys 95:3043112016

    • Search Google Scholar
    • Export Citation
  • 16

    Molina CAAmes CPChou DRhines LDHsieh PCZadnik PL: Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience. J Neurosurg Spine 21:3483562014

    • Search Google Scholar
    • Export Citation
  • 17

    Pennicooke BLaufer ISahgal AVarga PPGokaslan ZLBilsky MH: Safety and local control of radiation therapy for chordoma of the spine and sacrum: a systematic review. Spine (Phila Pa 1976) 41 (Suppl 20):S186S1922016

    • Search Google Scholar
    • Export Citation
  • 18

    Potluri SJefferies SJJena RHarris FBurton KEPrevost AT: Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine. Clin Oncol (R Coll Radiol) 23:1992082011

    • Search Google Scholar
    • Export Citation
  • 19

    Rich TASchiller ASuit HDMankin HJ: Clinical and pathologic review of 48 cases of chordoma. Cancer 56:1821871985

  • 20

    Rotondo RLFolkert WLiebsch NJChen YLPedlow FXSchwab JH: High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine 23:7887972015

    • Search Google Scholar
    • Export Citation
  • 21

    Rutz HPWeber DCSugahara STimmermann BLomax AJBolsi A: Extracranial chordoma: outcome in patients treated with function-preserving surgery followed by spot-scanning proton beam irradiation. Int J Radiat Oncol Biol Phys 67:5125202007

    • Search Google Scholar
    • Export Citation
  • 22

    Schwab JHHealey JHRose PCasas-Ganem JBoland PJ: The surgical management of sacral chordomas. Spine (Phila Pa 1976) 34:270027042009

    • Search Google Scholar
    • Export Citation
  • 23

    Snider JWSchneider RAPoelma-Tap DStieb SMurray FRPlacidi L: Long-term outcomes and prognostic factors after pencil-beam scanning proton radiation therapy for spinal chordomas: a large, single-institution cohort. Int J Radiat Oncol Biol Phys 101:2262332018

    • Search Google Scholar
    • Export Citation
  • 24

    Stieb SSnider JW IIIPlacidi LKliebsch ULomax AJSchneider RA: Long-term clinical safety of high-dose proton radiation therapy delivered with pencil beam scanning technique for extracranial chordomas and chondrosarcomas in adult patients: clinical evidence of spinal cord tolerance. Int J Radiat Oncol Biol Phys 100:2182252018

    • Search Google Scholar
    • Export Citation
  • 25

    Talac RYaszemski MJCurrier BLFuchs BDekutoski MBKim CW: Relationship between surgical margins and local recurrence in sarcomas of the spine. Clin Orthop Relat Res (397):1271322002

    • Search Google Scholar
    • Export Citation
  • 26

    Verlaan JJKuperus JSSlooff WBHennipman AOner FC: Complications, secondary interventions and long term morbidity after en bloc sacrectomy. Eur Spine J 24:220922192015

    • Search Google Scholar
    • Export Citation
  • 27

    Weber DCMalyapa RAlbertini FBolsi AKliebsch UWalser M: Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol 120:1691742016

    • Search Google Scholar
    • Export Citation
  • 28

    Weber DCMurray FCombescure CCalugaru VAlapetite CAlbertini F: Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy. Radiother Oncol 129:5205262018

    • Search Google Scholar
    • Export Citation
  • 29

    Wei FLiu ZLiu XJiang LDang GPassias PG: An approach to primary tumors of the upper cervical spine with spondylectomy using a combined approach: our experience with 19 cases. Spine (Phila Pa 1976) 43:81882018

    • Search Google Scholar
    • Export Citation
  • 30

    York JEBerk RHFuller GNRao JSAbi-Said DWildrick DM: Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg 90 (1 Suppl):73781999

    • Search Google Scholar
    • Export Citation
  • 31

    Zagars GKBallo MT: Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 56:4734812003

    • Search Google Scholar
    • Export Citation
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 355 355 147
Full Text Views 39 39 9
PDF Downloads 38 38 4
EPUB Downloads 0 0 0
PubMed
Google Scholar